Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,200 | 3 | 36.3% |
| Food and Beverage | $4,949 | 162 | 34.6% |
| Consulting Fee | $3,040 | 1 | 21.2% |
| Travel and Lodging | $1,116 | 6 | 7.8% |
| Education | $4.69 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $10,498 | 38 | $0 (2023) |
| GlaxoSmithKline, LLC. | $508.70 | 12 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $417.80 | 9 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $402.16 | 12 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $374.33 | 11 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $342.29 | 13 | $0 (2019) |
| PFIZER INC. | $341.44 | 26 | $0 (2020) |
| Novo Nordisk Inc | $337.13 | 7 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $242.68 | 11 | $0 (2018) |
| Abbott Laboratories | $197.04 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.23 | 1 | Abbott Laboratories ($20.23) |
| 2023 | $309.63 | 3 | E.R. Squibb & Sons, L.L.C. ($122.68) |
| 2021 | $88.78 | 1 | GlaxoSmithKline, LLC. ($88.78) |
| 2020 | $14.45 | 1 | PFIZER INC. ($14.45) |
| 2019 | $594.99 | 21 | Abbott Laboratories ($176.81) |
| 2018 | $5,360 | 62 | Gilead Sciences, Inc. ($3,951) |
| 2017 | $7,922 | 84 | Gilead Sciences Inc ($6,438) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2024 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Vascular | ||||||
| 11/16/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $122.68 | General |
| Category: Cardiovascular | ||||||
| 06/21/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $65.12 | General |
| 01/31/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $121.83 | General |
| 09/16/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $88.78 | General |
| Category: RESPIRATORY | ||||||
| 02/22/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/07/2019 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $176.81 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 10/19/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: STRUCTURAL HEART | ||||||
| 07/08/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/29/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $43.59 | General |
| 06/06/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: RESPIRATORY | ||||||
| 05/14/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/02/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $85.95 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: VACCINE | ||||||
| 04/01/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Bone Health | ||||||
| 03/26/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/20/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/19/2019 | Lilly USA, LLC | HUMULIN (Drug), TRULICITY | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Diabetes | ||||||
| 03/18/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Diabetes | ||||||
| 03/13/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: STRUCTURAL HEART | ||||||
| 03/06/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/05/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: DIABETES | ||||||
| 02/13/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/28/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ASMANEX | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,457 | 1,484 | $286,321 | $105,187 |
| 2022 | 14 | 1,431 | 1,472 | $268,702 | $106,927 |
| 2021 | 11 | 1,106 | 1,118 | $228,491 | $90,251 |
| 2020 | 9 | 656 | 668 | $130,478 | $43,928 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 652 | 672 | $141,120 | $52,580 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 266 | 268 | $81,740 | $30,692 | 37.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 161 | 162 | $15,714 | $8,145 | 51.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 54 | 54 | $16,632 | $4,615 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $7,376 | $2,649 | 35.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $5,278 | $2,096 | 39.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 21 | $2,793 | $1,163 | 41.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 66 | 66 | $4,224 | $1,069 | 25.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 56 | 56 | $3,584 | $908.32 | 25.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 12 | 13 | $2,444 | $394.16 | 16.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 103 | 106 | $2,014 | $361.46 | 17.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 24 | 24 | $2,544 | $326.83 | 12.8% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 13 | 13 | $858.00 | $186.34 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 490 | 512 | $103,424 | $42,013 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 316 | 323 | $94,962 | $38,223 | 40.3% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 199 | 207 | $19,251 | $10,477 | 54.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 35 | $13,720 | $6,150 | 44.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 52 | 52 | $15,444 | $4,786 | 31.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $5,340 | $1,297 | 24.3% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 58 | 59 | $3,599 | $962.31 | 26.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 19 | $2,432 | $932.24 | 38.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 55 | 55 | $3,355 | $881.01 | 26.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 126 | 128 | $2,304 | $434.72 | 18.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 24 | 24 | $2,448 | $318.77 | 13.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 17 | $1,224 | $240.14 | 19.6% |
About Dr. Johnson Adeyanju, M.D
Dr. Johnson Adeyanju, M.D is a Internal Medicine healthcare provider based in Concord, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467403147.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Johnson Adeyanju, M.D has received a total of $14,310 in payments from pharmaceutical and medical device companies, with $20.23 received in 2024. These payments were reported across 173 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5,200).
As a Medicare-enrolled provider, Adeyanju has provided services to 4,650 Medicare beneficiaries, totaling 4,742 services with total Medicare billing of $346,294. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Concord, CA
- Active Since 05/15/2006
- Last Updated 06/17/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1467403147
Products in Payments
- Vemlidy (Drug) $4,013
- ELIQUIS (Drug) $447.57
- Victoza (Drug) $318.61
- FARXIGA (Drug) $259.60
- BELSOMRA (Drug) $202.44
- XARELTO (Drug) $193.25
- CardioMEMS HF System (Device) $176.81
- TRELEGY ELLIPTA (Drug) $174.73
- ANORO (Drug) $172.69
- Nucynta (Drug) $127.79
- CHANTIX (Drug) $126.95
- VIAGRA (Drug) $115.19
- BYDUREON (Drug) $114.73
- JARDIANCE (Drug) $79.62
- TOUJEO (Drug) $70.02
- JANUVIA (Drug) $65.68
- AJOVY (Drug) $61.79
- INVOKANA (Drug) $49.43
- LYRICA (Drug) $48.16
- PNEUMOVAX 23 (Biological) $39.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Concord
Stephen Zouzoulas, Md, MD
Internal Medicine — Payments: $217,825
Manish Jain, Md, MD
Internal Medicine — Payments: $183,163
Dr. Roy Kaplan, M.d, M.D
Internal Medicine — Payments: $139,568
Dr. Anna Chang, M.d, M.D
Internal Medicine — Payments: $110,107
Santosh Rao, Md, MD
Internal Medicine — Payments: $44,301
Steven Park, Md, MD
Internal Medicine — Payments: $26,721